KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.900
-0.064 (-6.64%)
At close: Dec 5, 2025, 4:00 PM EST
0.888
-0.012 (-1.33%)
After-hours: Dec 5, 2025, 7:59 PM EST
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$943,184
Market Cap
7.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KALA News
- 1 day ago - KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Why Is Eye Disease Focused Kala Bio Stock Plunging On Monday? - Benzinga
- 4 months ago - Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool
- 4 months ago - KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 5 months ago - KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) - GlobeNewsWire
- 6 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 10 months ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire